H.R. 4534House118th Congress (2023-2025)Passed House

Women and Lung Cancer Research and Preventive Services Act of 2024

Introduced July 11, 2023

AI-Generated Summary

Updated January 20, 2026 at 9:43 AM UTC

The Women and Lung Cancer Research and Preventive Services Act of 2024 directs the Department of Health and Human Services, in consultation with the Departments of Defense and Veterans Affairs, to conduct an interagency review of lung cancer research focused on women and underserved populations. It aims to assess current research, identify gaps, improve access to preventive services, and develop public awareness campaigns, with a report to Congress due within two years. The bill primarily impacts federal agencies, women, and underserved groups eligible for lung cancer screening.

Key Provisions

  • HHS, together with the Defense and Veterans Affairs departments, must conduct a review of the status and gaps in lung cancer research for women and underserved populations.
  • The review must examine opportunities for collaborative, multidisciplinary research, including environmental and genomic factors and advances in imaging technology.
  • It must identify ways to expand a national lung cancer screening strategy, especially for women and underserved groups.
  • It must propose a national public education and awareness campaign about lung cancer in women, underserved populations, and the importance of early detection.
  • HHS must submit a comprehensive report of the review and recommendations to Congress no later than two years after the act’s enactment.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

15 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

December 17, 2024

View full timeline
HouseIntro Referral

Introduced in House

July 11, 2023

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

July 11, 2023

HouseCommittee

Referred to the Subcommittee on Health.

July 14, 2023

HouseCommittee

Subcommittee Consideration and Mark-up Session Held

May 16, 2024

HouseCommittee

Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 21 - 0.

May 16, 2024

HouseCommittee

Committee Consideration and Mark-up Session Held

June 12, 2024

HouseCommittee

Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.

June 12, 2024

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-622.

July 30, 2024

HouseCalendars

Placed on the Union Calendar, Calendar No. 520.

July 30, 2024

HouseFloor

Mr. Bucshon moved to suspend the rules and pass the bill, as amended.

December 16, 2024 • 3:58 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H7166-7167)

December 16, 2024 • 3:58 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 4534.

December 16, 2024 • 3:58 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)

December 16, 2024 • 4:06 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)

December 16, 2024 • 4:06 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

December 16, 2024 • 4:07 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

December 17, 2024

Floor Debate

4 members

What members said about H.R. 4534 on the floor

2 Republicans2 Democrats
Monica De La Cruz
Rep. Monica De La CruzR-TX-15 · Sep 12, 2023

Under clause 7 of rule XII, sponsors were added to public bills and resolutions, as follows: H.R. 16: Ms. Tokuda, Mr. Magaziner, Mr. Casten, Mr. Casar, Mr. Sherman, Ms. Caraveo, and Mr. Sablan. H.R.…

Brendan F. Boyle
Rep. Brendan F. BoyleD-PA-2 · Dec 16, 2024

Mr. Speaker, I thank my good friend from Florida (Ms. Castor) for yielding. Mr. Speaker, I rise today in strong support of my bill, the Women and Lung Cancer Research and Preventive Services Act of…

Kathy Castor
Rep. Kathy CastorD-FL-14 · Dec 16, 2024

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 4534, the Women and Lung Cancer Research and Preventive Services Act. This legislation led by…

Larry Bucshon
Rep. Larry BucshonR-IN-8 · Dec 16, 2024

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 4534) to require a review of women and lung cancer, and for other purposes, as amended. Mr. Speaker, I ask unanimous consent that all…

Bill Text

4 versions available

Reading Mode
Latest
Referred in SenateIssued December 17, 2024

IIB

118th CONGRESS

2d Session

H. R. 4534

IN THE SENATE OF THE UNITED STATES

December 17 (legislative day, December 16), 2024

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To require a review of women and lung cancer, and for other purposes.


1.

Short title

This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2024.

2.

Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns

(a)

In general

The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to—

(1)

research on lung cancer in women;

(2)

research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;

(3)

access to lung cancer preventive services; and

(4)

strategic public awareness and education campaigns on lung cancer.

(b)

Content

The review and recommendations under subsection (a) shall include—

(1)

a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;

(2)

opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—

(A)

encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;

(B)

evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and

(C)

foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;

(3)

opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and

(4)

opportunities regarding the development of a national public education and awareness campaign on—

(A)

lung cancer in women and underserved populations; and

(B)

the importance of early detection of lung cancer.

(c)

Report

Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).

Passed the House of Representatives December 16, 2024.

Kevin F. McCumber,

Clerk.